Skip to content

28th Annual TNP Conference Session F19 Evaluation -New Options in Hormone Receptor Positive Breast Cancer

28th Annual TNP Conference Session F19 Evaluation-New Options in Hormone Receptor + Breast Cancer

Speaker: Sharon Wilks
Friday, September 9, 2016

The objectives for this session were:
1) Update the group on the incidence and mortality rates of breast cancer and frequency that ER+ Breast Cancer occurs.
2) Review past and existing Strategies of Approach for ER+ Breast Cancer.
3) Explain the role of the Estrogen Receptor in Breast Cancer  
4) Review of the Current Understanding of key Signal Pathways that appears to influence tumor growth and resistance.
5) Update the participant on the New Strategies in Treatment that tackle Resistance in Estrogen Receptor Positive Breast Cancer 6) Review current treatments in the approach to Breast Cancer 
All of the identified objectives were met satisfactorily.(Required.)
The speaker was prepared and knowledgeable about the topic.(Required.)
The speaker was organized and effective.(Required.)
The teaching / learning strategies were effective for the content presented.(Required.)
The content was relevant to my nursing practice.(Required.)
The classroom facility was conducive to my learning.(Required.)
The content of the program was balanced and free of commercial bias.(Required.)
I would recommend offering this program again at a future conference.
Strongly Disagree
Disagree
No Opinion
Agree
Strongly Agree
I would recommend this speaker for future conference.
Strongly Disagree
Disagree
No Opinion
Agree
Strongly Agree